Also trades as: NAMSW (NASDAQ) · $vol 0M
NAMS NASDAQ
NewAmsterdam Pharma Company N.V.
1W: +2.8%
1M: -9.3%
3M: -33.5%
YTD: -34.1%
1Y: -21.0%
3Y: +154.9%
5Y: +135.5%
$23.20
-0.96 (-3.97%)
Weekly Expected Move ±8.4%
$19
$21
$23
$25
$27
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$7M
Revenue
-88.9% YoY
$-260M
Net Income
-56.6% YoY
$-144M
Free Cash Flow
-15.6% YoY
100.0%
Gross Margin
-1752.6%
Op. Margin
-1732.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-36.8%
ROA-34.2%
ROIC8216.2%
Valuation
P/E-10.6
P/B4.5
EV/EBITDA-13.9
Leverage
Debt/Equity0.00
Current Ratio9.03
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z32.43
Beneish M-4.66